Skip to main content
Caplight Logo









Smartox Biotechnology

Smartox Biotechnology

Private
FranceHealthcare & Life Scienceshttps://www.smartox-biotech.com/

Last Round

Series A

Mar 29, 2017

Total Funding Raised

$1.12M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Smartox Biotechnology is a biotechnology company that specializes in the research, discovery, and development of therapeutic peptides derived from animal venoms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS

AI Layer

Non-AI

Keywords

therapeutic peptidesdrug discoveryvenom-derived peptidespeptide synthesishigh-throughput screeningCROCDMOhit-to-leadresearch reagentsmass spectrometryHPLCion channel researchpeptide libraryvenom researchcontract research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Smartox Biotechnology Comparables

Compare Smartox Biotechnology with similar companies based on industry and business-model similarity.

Smartox Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ToxinTech
84%
Venomtech Limited
84%
Latoxan
80%

Smartox Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 29, 2017
SeedJul 9, 2014

Key People

Founding team and executive leadership

Rémy Beroud

CEO

Executive Team

Smartox Biotechnology Investors

Notable investors and investment history

Smartox Biotechnology investors
InvestorRounds
Crédit Agricole Alpes Développement (C2AD)Series A
WiSeedSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 167% MoM.

  • Jul 9, 2014

    $136K round led by WiSeed

Smartox Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Smartox Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Smartox Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrance
Employee Range9
Year Founded2011
Last FundingMar 29, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?